Most lately, it has been identified that conolidine and the above mentioned derivatives act around the atypical chemokine receptor three (ACKR3. Expressed in similar places as classical opioid receptors, it binds to some big range of endogenous opioids. Compared with most opioid receptors, this receptor acts as being a scavenger and will not activa